For the Inventor, By the Inventor

Enter assignee name

Johannes Gutenberg-Universität Mainz

USPTO Granted Patents = 44

CIPO Patents = 1

EPO Patents = 39

Forward Citations = 195

Loading Chart...

Loading Chart...

81 inventors (with patents filed for the assignee):

Ugur Sahin (25 out of 182 patents)

Michael Koslowski (22 out of 53 patents)

Ozlem Tureci (15 out of 53 patents)

4. Korden Walter (13 out of 18 patents)

5. Maria Kreuzberg (11 out of 15 patents)

6. Özlem Türeci (10 out of 52 patents)

7. Stefan Woll (9 out of 15 patents)

8. Bernd Hubner (8 out of 8 patents)

9. Michael Erdeljan (8 out of 8 patents)

10. Gerd Dannhardt (6 out of 13 patents)

11. Dirk Usener (5 out of 19 patents)

12. Michael Weichel (4 out of 4 patents)

13. Stefan Fritz (4 out of 9 patents)

14. Gunda Brandenburg (4 out of 9 patents)

15. Harald-Gerhard Geppert (4 out of 10 patents)

Core Competencies:

RNA Particles

Polysarcosine

Anyons

Electrochemical Oxidation

Star Polymers

Cancer Treatment

Claudin 6 Antibodies

Monoclonal Antibodies

Tumor Vaccination

T-cell Receptors

Molecular Imaging

Selectin Inhibitors

44 patents: Sort by Forward Citations

1. 12419965 - RNA particles comprising polysarcosine (2025-09-23),

2. 12389804 - Method and device for providing anyons, use of the device (2025-08-12),

3. 12366002 - Process for the oxidation of carbon-containing organic compounds with electrochemically generated oxidizing agents and arrangement for carrying out the process (2025-07-22),

4. 12037438 - Star polymers having a silyl coupling (2024-07-16),

5. 11859008 - Antibodies for treatment of cancer expressing claudin 6 (2024-01-02),

6. 11858988 - Antibodies specific for claudin 6 (CLDN6) (2024-01-02),

7. 11789621 - Method and system for controlling a switch in the execution mode of a processor (2023-10-17),

8. 11473085 - Methods and compositions for diagnosis and treatment of cancer (2022-10-18),

9. 11045449 - 3-(5-fluoroindolyl)-4-arylmaleimide compounds and their use in tumor treatment (2021-06-29),

10. 10919974 - Antibodies for treatment of cancer expressing claudin 6 (2021-02-16),

11. 10844133 - Cancer therapy using CLDN6 target-directed antibodies in vivo (2020-11-24),

12. 10745477 - Antibodies specific for claudin 6 (CLDN6) (2020-08-18),

13. 10233253 - Antibodies for treatment of cancer expressing claudin 6 (2019-03-19),

14. 10130722 - Bifunctional chelating agents based on the 1,4-diazepine scaffold (DAZA) for non-invasive molecular imaging (2018-11-20),

15. 10125196 - Monoclonal antibodies for treatment of cancer (2018-11-13),

Johannes Gutenberg-Universität Mainz is a prominent research university located in Mainz, Germany. Established in 1477, it is named after Johannes Gutenberg, the inventor of the printing press. The university offers a wide range of programs across various disciplines, including humanities, social sciences, natural sciences, and medicine. With a strong emphasis on research and innovation, it fosters a vibrant academic community and collaborates with numerous institutions worldwide. The university is known for its commitment to interdisciplinary studies and its role in advancing knowledge and education in the region.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

44 Patents

#8 in Mainz

#1,217 in Germany

#15,296 in the World

Johannes Gutenberg-Universität Mainz

Forward Citations = 195

81 inventors:

Ugur Sahin (25 out of 182 patents)

Michael Koslowski (22 out of 53 patents)

Ozlem Tureci (15 out of 53 patents)

4. Korden Walter (13 out of 18 patents)

5. Maria Kreuzberg (11 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…